期刊文献+

血浆内脂素、一氧化氮与2型糖尿病及糖尿病肾病的关系研究 被引量:3

The research on the relativity between plasma visfatin,nitric oxide and type 2 diabetes and diabetic nephropathy
下载PDF
导出
摘要 目的:探讨血浆内脂素与一氧化氮(NO)和相关代谢指标的关系,及其在2型糖尿病及糖尿病肾病(DN)发展过程中的作用及关系。方法:选取糖尿病患者72例,其中合并DN(DN组)40例,未合并DN(nDN组)32例,并选取年龄及体重指数(BMI)匹配的正常对照组24名。用酶联免疫法检测血浆内脂素的水平,硝酸还原酶法测定血浆NO水平,同时检测血糖、血脂、胰岛素、C肽、胰岛素原、胰高血糖素、BMI、腰臀比(WHR)、超敏C反应蛋白等相关指标。用胰岛素抵抗指数(HOMA-IR)评价胰岛素抵抗,胰岛素分泌指数评价胰岛β细胞分泌情况,分析各指标间的相关性及与DN的相关性。结果:3组血浆内脂素水平分别为47.46±3.94、50.24±4.93、27.22±4.39,差异有统计学意义(P<0.01)。3组血浆NO水平分别为52.05±6.14、44.05±6.43、61.01±4.76,差异亦有统计学意义(P<0.01)。DN组血浆内脂素浓度与NO、HOMA-IR、空腹胰岛素、腰围、WHR、甘油三酯呈正相关。HOMA-IR、WHR是血浆内脂素的独立影响因素。结论:血浆内脂素、NO与2型糖尿病及合并DN有关。 Objective:To explore the relationships of visfatin,nitric oxide(NO) and the metabolic markers and observe their roles in type 2 diabetes and the development in diabetic nephropathy(DN).Methods:Seventy-two patients with diabetes,in which 40 patients with diabetic nephropathy and 32 patients without complications were selected,and 24 healthy control cases whose age and body mass index(BMI) matched were also selected.The plasma level of visfatin was measured by enzyme-linked immunosorbent assay,and the level of plasma NO was measured by nitrate reductase method.While blood glucose,blood lipids,insulin,C peptide,proinsulin,glucagon,BMI,waist-hip ratio(WHR),high sensitivity C-reative protein and other related indicators were also measured.Insulin resistance was evaluated by insulin resistance index the homeostasis model assessment-IR(HOMA-IR),and insulin secretion index the HOMA-β was used to evaluate β-cell insulin secretion.The correlation between each index and microvascular complications of diabetes and diabetic nephropathy were analyzed.Results:The levels of plasma visfatin were 47.46±3.94,50.24±4.93,and 27.22±4.39 in diabetes cases without DN(nDN),diabetic cases with DN and control group respectively,and there had statistical differences among the three groups(P〈0.01);the plasma NO levels were 52.05±6.14,44.05±6.43,61.01±4.76 in diabetic patients nDN,diabetes with DN and control group,which had statistical differences(P〈0.01).The correlation analysis showed that there had positively correlation with the plasma visfatin level and the concentrations of NO,HOMA-IR,fasting insulin,waist circum ference,WHR,triglyceride in type 2 diabetes.Furtherly,HOMA-IR,WHR were independently associated with visfatin.Conclusions:Plasma visfatin and NO were related with type 2 diabetes and DN.
出处 《蚌埠医学院学报》 CAS 2012年第3期267-270,共4页 Journal of Bengbu Medical College
关键词 糖尿病 糖尿病肾病 血浆内脂素 一氧化氮 肥胖 diabetes diabetic nephropathy visfatin nitric oxide obesity
  • 相关文献

参考文献3

二级参考文献19

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2刘蓉,朱剑,王茜,沈备,刘翠萍,徐宽枫,茅晓东,刘超.不同糖耐量人群及糖尿病患者血浆内脂素与血糖及胰岛功能的关系研究[J].中国实用内科杂志,2007,27(16):1278-1281. 被引量:89
  • 3Samal B,Sun Y,Stearns G,et al.Cloning and characterization of the cDNA encoding a novel human pre-B-cell colonyenhancing factor.Mol Cell Biol,1994,14:1431-1437.
  • 4Jia SH,Li Y,Parodo J,et al.Pre-B-cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinicsl sepsis.J Clin Invest,2004,113:1318-1327.
  • 5Fujiki K,Shin DH,Nakao M,et al.Molecular cloning and expression analysis of the putative carp(Cyprinus carpio)pre-B-cell enhancing factor.Fish Shellfish Immunol,2000,10:383-385.
  • 6Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin.Seience,2005,307:426-430.
  • 7Muller WE,Perovic S,Wilkesman J,et al.Increased gene expression of a cytokine-related molecule and profilin after activation of Suberites domuncula cells with xenogeneic sponge molecule(s).DNA Cell Biol,1999,18:885-893.
  • 8Ognjanovic S,Bryant-Greenwood GD.Pre-B-cell colony-enhancing factor,a novel cytokine of human fetal membranes.Am J Obstet Gynecol,2002,187:1051-1058.
  • 9Jia SH,Li Y,Parodo J,et al.Pre-B-cell colony-enhancing factor inhibits neutrophil apoptosis in exoerimental inflammation and clinical sepsis.J Clin Invest,2004,113:1318-1327.
  • 10Kralisch S,Klein J,Lossner U,et al.Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytesc.J Endocrinol,2005,185:R1-R8.

共引文献22

同被引文献33

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志(电子版),2011,6(3):54109.
  • 2Gordin D, Forsblom C, Panduru NM,et al.Osteopontin is a strong predictor of incipient diabetic nephropathy,cardio- vascular disease,and all-cause mortality in patients with type 1 diabetes[J].Diabetes Care,2014,37(9):2593-2600.
  • 3傅明捷,黄萍,王艳,等.糖尿病肾病患者蛋白尿与C反应蛋白、肿瘤坏死因子-α和白介素-6水平关系的临床研究[J].中国医药导报,2013,10(15):89-90.
  • 4Mori J, Patel VB, Ramprasath T,et al.Angiotensin 1-7 me- diates renoprotection against diabetic nephropathy by re- ducing oxidative stress,inflammation,and lipotoxicity [J]. Am J Physiol Renal Physiol,2014,306(8):F812-F821.
  • 5Kwakernaak AJ,Krikken JA,Binnenmars SH,et al.Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy:a randomised clinical trial[J].Lancet Diabetes Endocrinol, 2014,2 (5) :385- 395.
  • 6Berezin AE,Kremzer AA.Circulating osteopontin as a mark- er of early coronary vascular calcification in type two dia- betes mellitus patients with known asymptomatic coronary artery disease[J].Atherosclerosis, 2013,229 (2) : 475 -481.
  • 7Heuer JG,Breyer MD.Osteopontin in diabetic nephropa- thy: signpost or road?[J].Kidney Int,2010,77 (7) : 565-566.
  • 8Pek SL,Tavintharan S,Wang X,et al.Elevation of a novel angiogenic factor,leucine-rich-a2-glycoprotein(LRG1),is associated with arterial stiffness,endothelial dysfunction and peripheral arterial disease in patients with type 2 diabetes[J].J Clin Endocrinol Metab,2015,100(4):1586-1593.
  • 9Hotamisligil GS.Inflammation and metabolic disorders[J].Nature,2006,444(7121):860-867.
  • 10Zhan Y,Dong Y,Tang Z,et al.Serum Uric Acid,Gender,and Low Ankle Brachial Index in Adults With High Cardiovascular Risk[J].Angiology,2015,66(7):687-691.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部